Crohn's Disease

Show Only Open Trials
1.

SECURE: A Non-Interventional Long-term Post-Marketing Registry of Patients Treated with Certolizumab Pegol (Cimzia®) for Crohn's Disease

  • Study Status: Open to Enrollment
  • Sponsor: UCB Pharma
  • Disease Status and/or Stage: Crohn's disease
  • Protocol ID: WCMC IRB Protocol # 0906010458
2.

Evaluation of PROCHYMAL Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease

  • Study Status: Open to Enrollment
  • Sponsor: Osiris
  • Disease Status and/or Stage: Moderate to Severe Crohn's Disease
  • Protocol ID: Osiris 603
3.

CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring

  • Study Status: Open to Enrollment
  • Sponsor: Elan Pharmaceuticals
  • Disease Status and/or Stage: Crohn's Disease Being Treated with TYSABRI
4.

The Multi-Center African American IBD Study (MAAIS)

  • Study Status: Open to Enrollment
  • Sponsor: National Institutes of Digestive Diseases and Kidney (NIDDK)
  • Disease Status and/or Stage: African-Americans with IBD, a Family Member with IBD, or Healthy Volunteers
5.

A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease

  • Study Status: Open to Enrollment
  • Sponsor: Crohn’s Colitis Foundation Clinical Alliance
  • Disease Status and/or Stage: Pregnant Women with Crohn's Disease or Ulcerative Colitis

Top of page